Low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer

P Szturz, K Wouters, N Kiyota, M Tahara… - Frontiers in …, 2019 - frontiersin.org
In locally advanced squamous cell carcinomas of the head and neck (LA-SCCHN),
concurrent chemoradiotherapy is an integral part of multimodality management both in the …

Cancer combination therapies with artemisinin-type drugs

T Efferth - Biochemical pharmacology, 2017 - Elsevier
Artemisia annua L. is a Chinese medicinal plant, which is used throughout Asia and Africa
as tea or press juice to treat malaria. The bioactivity of its chemical constituent, artemisinin is …

Follow-up of head and neck cancer survivors: tipping the balance of intensity

P Szturz, C Van Laer, C Simon, D Van Gestel… - Frontiers in …, 2020 - frontiersin.org
The traditional concept of post-treatment surveillance in head and neck cancer patients
relies on examinations directed at early detection of disease recurrence and/or second …

Gastrostomy tube dependence and patient‐reported quality of life outcomes based on type of treatment for human papillomavirus‐associated oropharyngeal cancer …

DL Quan, A Sukari, M Nagasaka, H Kim… - Head & …, 2021 - Wiley Online Library
We examined the impact of treatment modality on gastrostomy tube dependence and patient‐
reported outcomes in human papillomavirus‐associated oropharyngeal cancer (HPV …

Design and fabrication of a 3D–printed oral stent for head and neck radiotherapy from routine diagnostic imaging

CT Wilke, M Zaid, C Chung, CD Fuller… - 3D Printing in …, 2017 - Springer
Background Oral stents have been shown to reduce the deleterious effects of head and neck
radiotherapy through the displacement of normal tissues away from the areas of high dose …

Patient‐reported quality‐of‐life outcomes after de‐escalated chemoradiation for human papillomavirus‐positive oropharyngeal carcinoma: Findings from a phase 2 …

JV Hegde, N Shaverdian, ME Daly, C Felix, DL Wong… - Cancer, 2018 - Wiley Online Library
BACKGROUND The current study represents a subset analysis of quality‐of‐life (QOL)
outcomes among patients treated on a phase 2 trial of de‐escalated chemoradiation for …

Radiation therapy for cT1-2 carcinoma of the palatine tonsil diagnosed via a simple tonsillectomy: Dosimetry and patterns of care in the IMRT era

MC Ward, ML Wallander, JG Kuremsky, R Dhakal… - Oral Oncology, 2023 - Elsevier
Objective Small carcinomas of the palatine tonsil are often diagnosed via simple
tonsillectomy, a maneuver with non-therapeutic intent. Herein, practice patterns for this …

Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma

S Baker, GM Verduijn, S Petit, A Sewnaik, H Mast… - Acta …, 2019 - Taylor & Francis
Background/purpose: To determine the efficacy and toxicity profile of a stereotactic body
radiotherapy (SBRT) boost as a first line treatment in patients with oropharyngeal squamous …

[HTML][HTML] Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients

P Szturz, M Vinches, É Remenár… - European Journal of …, 2021 - Elsevier
Abstract Background In the TAX 323 (EORTC 24971) phase III trial enrolling patients with
unresectable locoregionally advanced squamous cell carcinoma of the head and neck (LA …

Functional outcomes after de-escalated chemoradiation therapy for human papillomavirus–positive oropharyngeal cancer: secondary analysis of a phase 2 trial

JV Hegde, N Shaverdian, C Felix, PC Wang… - International Journal of …, 2018 - Elsevier
Purpose To analyze functional outcomes for patients treated on a phase 2 trial of de-
escalated chemoradiation therapy for human papillomavirus–positive oropharyngeal …